Latest AI and machine learning research in oncology/hematology for healthcare professionals.
BACKGROUND: The Ki-67 antigen, a marker of cell proliferation, serves as a biomarker for assessing tumor malignancy. However, measuring Ki-67 levels through immunohistochemistry is often challenging due to difficulties in specimen collection and individual health issues. Radiological analysis has emerged as a potential alternative for predicting Ki-67 levels, although its accuracy has been limited...
BACKGROUND: This study was conducted to assess the efficacy and safety of magnetic resonance (MR)-guided hypofractionated radiotherapy in patients with unresectable hepatocellular carcinoma (HCC). Machine learning-based radiomics was utilized to predict responses in these patients.
OBJECTIVES: Oral cavity-derived cancer pathological images (OPI) are crucial for diagnosing oral squamous cell carcinoma (OSCC), but existing deep lea...
INTRODUCTION: Increasing evidence highlights the pivotal role of RNA methylation and miRNAs in hepatocellular carcinoma (HCC). However, the risk assoc...
BACKGROUND: Lung adenocarcinoma (LUAD) is a major cause of cancer mortality. Considering the critical role of tumor infiltrating lymphocytes in effect...
Prostate cancer is the second most common cancer among men worldwide. This cancer has become extremely noticeable due to the increase of prostate can...
The important function of microbiota as therapeutic modulators and diagnostic biomarkers in cancer has been shown by recent developments in microbiome...
BACKGROUND: Although immune checkpoint inhibitors (ICIs) represent a substantial breakthrough in cancer treatment, it is crucial to acknowledge that t...
Breast cancer (BC) is the most common malignant tumor among women worldwide, posing a substantial threat to their health and overall quality of life. ...
OBJECTIVE: To establish a combined model based on ultrasound radiomics combined with multimodal ultrasound and evaluate its value in diagnosing benign...
BACKGROUND: Cervical squamous cell carcinoma (CESC) constitutes a substantial global health burden, especially in resource-limited regions. The identi...
The present study aimed to evaluate the feasibility of patient-generated text and its interpretation by artificial intelligence (AI) as a valid correl...
Uterine corpus endometrial carcinoma (UCEC) is a gynecological malignancy with poor prognosis and high lethality rates. Pyroptosis, a pro-inflammator...
Advancements in medical imaging technology have facilitated the acquisition of high-quality brain images through computed tomography (CT) or magnetic ...
Oral squamous cell carcinoma (OSCC) remains the most prevalent neoplasm of the head and neck. In recent decades, the incidence and prevalence of OSCC ...
Survival is the gold standard in oncology when determining the real impact of therapies in patients outcome. Thus, identifying molecular predictors of...
BACKGROUND: Breast cancer is a heterogeneous malignancy with complex molecular characteristics, making accurate prognostication and treatment stratifi...
OBJECTIVE: To develop and validate an interpretable machine learning (ML) model for the preoperative prediction of central lymph node metastasis (CLNM...
BACKGROUND: Triple-negative breast cancer (TNBC) is a highly aggressive subtype with limited therapeutic targets and poor immunotherapy outcomes. The ...
BACKGROUND: Programmed cell death (PCD) refers to a regulated and active process of cellular demise, initiated by specific biological signals. PCD pla...